| Global Tuberculosis Control World Health Organization | 36073* | 2008 |
| Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country C Dye, S Scheele, V Pathania, MC Raviglione Jama 282 (7), 677-686, 1999 | 4877 | 1999 |
| The growing burden of tuberculosis: global trends and interactions with the HIV epidemic EL Corbett, CJ Watt, N Walker, D Maher, BG Williams, MC Raviglione, ... Archives of internal medicine 163 (9), 1009-1021, 2003 | 4171 | 2003 |
| The effect of human mobility and control measures on the COVID-19 epidemic in China MUG Kraemer, CH Yang, B Gutierrez, CH Wu, B Klein, DM Pigott, ... Science 368 (6490), 493-497, 2020 | 3027 | 2020 |
| Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model RM Granich, CF Gilks, C Dye, KM De Cock, BG Williams The Lancet 373 (9657), 48-57, 2009 | 2467 | 2009 |
| An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China H Tian, Y Liu, Y Li, CH Wu, B Chen, MUG Kraemer, B Li, J Cai, B Xu, ... Science 368 (6491), 638-642, 2020 | 2078 | 2020 |
| Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections WHO Ebola Response Team New England Journal of Medicine 371 (16), 1481-1495, 2014 | 2010 | 2014 |
| Genomics and epidemiology of the P. 1 SARS-CoV-2 lineage in Manaus, Brazil NR Faria, TA Mellan, C Whittaker, IM Claro, DS Candido, S Mishra, ... Science 372 (6544), 815-821, 2021 | 1580 | 2021 |
| Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness BB Trunz, PEM Fine, C Dye The Lancet 367 (9517), 1173-1180, 2006 | 1442 | 2006 |
| Drivers of tuberculosis epidemics: the role of risk factors and social determinants K Lönnroth, E Jaramillo, BG Williams, C Dye, M Raviglione Social science & medicine 68 (12), 2240-2246, 2009 | 1388 | 2009 |
| Heterogeneities in the transmission of infectious agents: implications for the design of control programs MEJ Woolhouse, C Dye, JF Etard, T Smith, JD Charlwood, GP Garnett, ... Proceedings of the National Academy of Sciences 94 (1), 338-342, 1997 | 1327 | 1997 |
| Estimates of world-wide distribution of child deaths from acute respiratory infections BG Williams, E Gouws, C Boschi-Pinto, J Bryce, C Dye The Lancet infectious diseases 2 (1), 25-32, 2002 | 1285 | 2002 |
| Global epidemiology of tuberculosis C Dye The Lancet 367 (9514), 938-940, 2006 | 1141 | 2006 |
| Global trends in resistance to antituberculosis drugs MA Espinal, A Laszlo, L Simonsen, F Boulahbal, SJ Kim, A Reniero, ... New England Journal of Medicine 344 (17), 1294-1303, 2001 | 1106 | 2001 |
| Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence EC Sabino, LF Buss, MPS Carvalho, CA Prete, MAE Crispim, NA Fraiji, ... The Lancet 397 (10273), 452-455, 2021 | 929 | 2021 |
| Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries MA Espinal, SJ Kim, PG Suarez, KM Kam, AG Khomenko, GB Migliori, ... Jama 283 (19), 2537-2545, 2000 | 916 | 2000 |
| Global incidence of multidrug-resistant tuberculosis M Zignol, MS Hosseini, A Wright, CL Weezenbeek, P Nunn, CJ Watt, ... The Journal of infectious diseases 194 (4), 479-485, 2006 | 849 | 2006 |
| The population dynamics and control of tuberculosis C Dye, BG Williams Science 328 (5980), 856-861, 2010 | 806 | 2010 |
| Alcohol use as a risk factor for tuberculosis–a systematic review K Lönnroth, BG Williams, S Stadlin, E Jaramillo, C Dye BMC public health 8, 1-12, 2008 | 790 | 2008 |
| Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally C Dye, CJ Watt, DM Bleed, SM Hosseini, MC Raviglione Jama 293 (22), 2767-2775, 2005 | 781 | 2005 |
Mario RaviglioneProfessor of Global Health, University of Milan, Italy在 unimi.it 的电子邮件经过验证
